US 8501798
Dual-acting antihypertensive agents
granted A61PA61P43/00A61P9/00
Quick answer
US patent 8501798 (Dual-acting antihypertensive agents) held by Theravance, Inc. expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P43/00, A61P9/00, A61P9/04, A61P9/12